We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

A picture of Sarah Whelan, PhD

Sarah Whelan, PhD profile page

Science Writer

 at Technology Networks

Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.


University of Kent  

University of Leicester  

Areas of Expertise

Got a Question for Sarah Whelan, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content
Total: 281
A person holding two packages of red meat in a supermarket.

Could Genetics Influence Cancer Risk From Red and Processed Meats?

Researchers have explored whether genetics can influence the risk of colorectal cancer from the consumption of red and processed meat, identifying two genetic markers that may put some people at increased risk.
A scientist holding a rack of tubes in a laboratory.

Alzheimer’s Drug Production a Step Closer With the Help of Bacteria and AI

Researchers have developed a microbial fermentation method to produce galantamine with the help of artificial intelligence (AI) and biosensors.
A digital illustration of a DNA double helix.

Genetic “Dark Matter” Could Help Monitor Cancer

Researchers from the Johns Hopkins Kimmel Cancer Center have developed a machine-learning approach that identifies these sequences in both tumor DNA and cell-free DNA (cfDNA) that are shed into the blood.
A digital illustration of a neuron and synapses.

FDA To Delay Decision on New Alzheimer’s Drug Candidate

A candidate drug for Alzheimer’s disease, donanemab, will be further scrutinized by a US Food and Drug Administration (FDA) expert panel, drugmaker announces.
A microscope image showing hair follicle stem cells in the skin's epidermis.

Vitamin A’s Role in Skin Influences Wound Repair and Hair Growth

Retinoic acid, a form of vitamin A, can regulate lineage plasticity in skin stem cells, suggests a new study that could have clinical implications for regenerative medicine, wound healing and even cancer.
A digital illustration of a brain emitting multi-colored strands.

Experimental Drug Shows Early Promise for Rare, Incurable Brain Tumors

A study of five early-stage clinical trials has found that an experimental drug may have favorable results for a rare and incurable type of brain tumor, for which there are very few treatment options.
A digital anatomical illustration of the human brain.

Stimulating Brain Waves May Protect Against “Chemobrain”

A method to stimulate gamma brain waves could pave the way for a non-invasive treatment for so-called “chemobrain”, according to a new study from MIT researchers.
A network of icons indicating connections in technology.
Industry Insight

Using Predictive Tools To Bring Drugs to Market Faster

We spoke to Olivier Barberan, director of Translational Medicine Solutions at Elsevier, to find out more about how predictive tools can inform pharma companies and help pave the way for drugs to get to market.
Computer-generated image of cancer cells.

Gut Microbiome May Identify Cancer Patients Who Will Respond to Immunotherapy

A signature of bacterial strains in the gut microbiome may be able to identify cancer patients that will respond well to certain immunotherapy drug combinations, according to a new study from Wellcome Sanger Institute and Olivia Newton-John Cancer Research Institute researchers.
An illustration of interactions between the gut and the brain.

The Gut–Brain Axis May Not Operate as Previously Thought

New information on how the gut and brain communicate has been uncovered by Flinders University researchers in a development that could influence how we make and use certain drugs, such as antidepressants.